Status
Conditions
Treatments
About
Hyperphosphatemia is a common problem in hemodialysis (HD) patients. Different chelators for control of Hyperphosphatemia are used. The aim of this study was to assess the effect of magnesium oxide (Mg Oxide) on the control of serum phosphorus (P) level and evaluation of its side effects in hemodialysis patients.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
hemodialysis with duration>3 months serum P level >5.5 mg/dl serum Ca>8 mg/dl.
Exclusion criteria
Mg level >3 mg/dl
42 participants in 2 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal